CD82 and breast carcinoma: This recommendation is based on their finding that the KAI1 is expressed on exosomes that are excreted into body fluids, and this exosomal KAI1 had an inverse relation with the stage of breast cancer; the more advanced stages showed lower expression of exosomal KAI1.